Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07288827 · ClinicalTrials.gov registry record · NA

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

A NA study of Healthy and Primary Ciliary Dyskinesia, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07288827 is a NA study of Healthy and Primary Ciliary Dyskinesia that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07288827, a NA study of Healthy and Primary Ciliary Dyskinesia, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at children with PCD and see if they have another condition called "bronchial hyperresponsiveness".

Interventions

  • PROCEDURE Lung Function Testing
  • PROCEDURE Phlebotomy
  • PROCEDURE Allergy skin prick testing
  • PROCEDURE Methacholine Challenge

Study Locations (1)

Indiana

  • Riley Hospital for Children - Indianapolis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-05-04
Est. Completion 2028-04-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT07288827

The ClinicalTrials.gov registry entry for NCT07288827 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Lung Function Testing is the first listed.

NCT07288827 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT07288827 about?

NCT07288827 is a clinical study titled "Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia". The purpose of this study is to look at children with PCD and see if they have another condition called "bronchial hyperresponsiveness".

What is the current status of trial NCT07288827?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-04. Estimated completion is 2028-04-30.

What conditions does trial NCT07288827 study?

This clinical trial studies the following conditions: Healthy, Primary Ciliary Dyskinesia.

What interventions are being tested in trial NCT07288827?

The interventions under investigation include: Lung Function Testing (PROCEDURE), Phlebotomy (PROCEDURE), Allergy skin prick testing (PROCEDURE), Methacholine Challenge (PROCEDURE).

Who is sponsoring clinical trial NCT07288827?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07288827 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.